Current Protocols in Neuroscience

Editors & Contributors

---

EDITORIAL BOARD

Charles R. Gerfen
Bethesda, Maryland

Andrew Holmes
Bethesda, Maryland

David Sibley
Bethesda, Maryland

Phil Skolnick
Bethesda, Maryland

Susan Wray
Bethesda, Maryland

PAST EDITORS

Jacqueline N. Crawley

Ron McKay

Michael A. Rogawski

CONTRIBUTORS

Evelyn Abordo-Adesida
University of Manchester
Manchester, United Kingdom

Karen Ackroff
Brooklyn College of the City University of New York
Brooklyn, New York

Stephen T. Ahlers
Naval Medical Research Center
Silver Spring, Maryland

Karl E. O. Åkerman
Uppsala University
Uppsala, Sweden

Paul R. Albert
University of Ottawa
Ottawa, Canada

John A. Alberta
Harvard Medical School and Dana-Farber Cancer Institute
Boston, Massachusetts

Roger L. Albin
University of Michigan and Ann Arbor Veterans Administration Medical Center
Ann Arbor, Michigan

Hussien A. Al-Shamma
Arena Pharmaceuticals
San Diego, California

William W. Anderson
MRC Centre for Synaptic Plasticity
Bristol, United Kingdom

Paula K. Andrus
Pharmacia & Upjohn
Kalamazoo, Michigan

Hymie Anisman
Carleton University
Ottawa, Canada

Srdjan Antic
Yale University School of Medicine
New Haven, Connecticut

Marjorie A. Ariano
The Chicago Medical School
North Chicago, Illinois

H. Moore Arnold
Sention Pharmaceutical
Providence, Rhode Island

Alejandro Aruffo
Bristol-Myers Squibb
Princeton, New Jersey

Jaime Athos
University of Washington
Seattle, Washington

Didier Bagnol
Arena Pharmaceuticals
San Diego, California

Jason A. Bailey
Institute of Psychiatric Research
Indiana University School of Medicine
Indianapolis, Indiana

Krys S. Bankiewicz
University of California
San Francisco, California

Anthony W. Bannon
Amgen, Inc.
Thousand Oaks, California

Jeffery L. Barker
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

James E. Barrett
Memory Pharmaceuticals
Montvale, New Jersey

Erin S. Barry
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Anthony Basile
National Institute of Diabetes and Digestive & Kidney Diseases
National Institutes of Health
Bethesda, Maryland

Philippe I. H. Bastiaens
Max Planck Institute for Molecular Physiology
Dortmund, Germany

Kathleen Baynes
University of California at Davis
Davis, California

Patrick M. Beardsley
Virginia Commonwealth University
Richmond, Virginia

Bernard Beer
DOV Pharmaceutical, Inc.
Hackensack, New Jersey

Dominic Behan
Arena Pharmaceuticals
San Diego, California

Leonardo Belluscio
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Jesús Benavides
Synthélabo Recherche
Bagneux Cédex, France

Kendra Bence-Hanulec
Brown University
Providence, Rhode Island

Mark H. Bender
Eli Lilly & Company
Indianapolis, Indiana

Gary J. Bennett
McGill University
Montreal, Quebec, Canada

Marcelle Bergeron
Lilly Research Laboratories
Indianapolis, Indiana

Alain Bernard
Ares-Serono Pharmaceutical Research Institute
Geneva, Switzerland

Leslie Blair
Brown University
Providence, Rhode Island

D. Caroline Blanchard
University of Hawaii
Honolulu, Hawaii

Robert J. Blanchard
University of Hawaii
Honolulu, Hawaii

Anne J. Blaschke
University of California at San Diego School of Medicine
La Jolla, California

Kenneth D. Bloch
Massachusetts General Hospital
Charleston, Massachusetts

John Blundell
University of Leeds
Leeds, United Kingdom

Oliver Bögler
Medical College of Virginia
Richmond, Virginia

Kathleen M. K. Boje
University at Buffalo School of Pharmacy
Buffalo, New York

Antonello Bonci
National Institute on Drug Abuse—Intramural Research Program
National Institutes of Health
Baltimore, Maryland

Lisa M. Bonnici
University of California at Davis
Davis, California

Richard Bookman
University of Miami School of Medicine
Miami, Florida

Zuner A. Bortolotto
MRC Centre for Synaptic Plasticity
Bristol, United Kingdom

Amy C. Boudreau
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

Jim Boulter
University of California at Los Angeles
Los Angeles, California

Christopher Boyer
The Salk Institute
La Jolla, California

Jonathan P. Britt
National Institute on Drug Abuse—Intramural Research Program
National Institutes of Health
Baltimore, Maryland

Thomas Brody
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Andrew Bradbury
Los Alamos National Laboratory
Los Alamos, New Mexico
and International School for Advanced Studies (SISSA)
Trieste, Italy

Roger Brent
The Molecular Sciences Institute
Berkeley, California

Bill Brizzard
Eastman Kodak Company
New Haven, Connecticut

Geneviève Brossard
Porsolt and Partners Pharmacology
Boulogne-Billancourt, France

Patricia Brown
Office of Animal Care and Use, NIH
Bethesda, Maryland

Terry Brown
University of Manchester Institute of Science and Technology
Manchester, United Kingdom

Susan A. Brunelli
Columbia University and Sackler Institute for Developmental Psychobiology
and New York State Psychiatric Institute
New York, New York

John P. Bruno
The Ohio State University
Columbus, Ohio

Oliver Brüstle
University of Bonn
Bonn, Germany

Wayne R. Buck
The Ohio State University
Columbus, Ohio

James R. Bunzow
Oregon Health Sciences University
Portland, Oregon

Linda Buonocore
Yale University School of Medicine
New Haven, Connecticut

Michael C. Byrne
Genetics Institute/Wyeth Research
Cambridge, Massachusetts

S. Barak Caine
McLean Hospital, Harvard Medical School
Belmont, Massachusetts

Heather A. Cameron
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

J. Patrick Card
University of Pittsburgh
Pittsburgh, Pennsylvania

Galen Carey
MPI Research
Mattawan, Michigan

Rebecca J. Carter
University of Cambridge
Cambridge, United Kingdom

Maria G. Castro
University of Manchester
Manchester, United Kingdom

Vineeta Chand
University of Essex
Colchester, United Kingdom

Vladimir I. Chefer
National Institute on Drug Abuse Intramural Research Program
National Institutes of Health
Baltimore, Maryland

Claudia A. Chen
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Jonathan D. Chesnut
Invitrogen Corporation
Carlsbad, California

Marie-Francoise Chesselet
UCLA School of Medicine
Los Angeles, California

Dennis W. Choi
Washington University School of Medicine
St. Louis, Missouri

Piotr Chomczynski
University of Cincinnati College of Medicine
Cincinnati, Ohio

Richard Chubet
Eastman Kodak Company
New Haven, Connecticut

Jerold Chun
University of California at San Diego School of Medicine
La Jolla, California

Jin Mo Chung
Marine Biomedical Institute
Galveston, Texas

Valentina Ciccarone
Life Technologies, Inc.
Rockville, Maryland

James A. Clemens
Lilly Corporate Center
Indianapolis, Indiana

Lawrence B. Cohen
Yale University School of Medicine
New Haven, Connecticut

Raymond J. Colello
School of Medicine
Virginia Commonwealth University
Richmond, Virginia

John E. Coligan
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland

Donald Coling
University of California
Berkeley, California

Graham L. Collingridge
MRC Centre for Synaptic Plasticity
Bristol, United Kingdom

Kelly L. Conrad
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

Anis Contractor
The Salk Institute for Biological Studies
La Jolla, California

Helen M. Cooper
Ludwig Institute for Cancer Research
Melbourne, Australia

Brendan Cormack
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mike Cousin
University of Edinburgh
Edinburgh, United Kingdom

Ian Creese
Rutgers University Center for Molecular and Behavioral Neuroscience
Newark, New Jersey

Peter Crino
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania

John F. Cryan
University College Cork
Cork, Ireland

Alex Cummins
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Christopher L. Cunningham
Oregon Health Sciences University
Portland, Oregon

Miles G. Cunningham
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Nathan Dascal
Tel Aviv University
Ramat Aviv, Israel

Judith A. Davis
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Michael Davis
Emory University School of Medicine
Atlanta, Georgia

Gerry Dawson
The Neuroscience Research Centre
Merck, Sharp and Dohme
Terlings Park, United Kingdom

Jeremy J. Day
Department of Neurobiology and Evelyn F. McKnight Brain Institute
University of Alabama at Birmingham
Birmingham, Alabama

Kerry R. Delaney
Simon Fraser University
Burnaby, British Columbia, Canada

Luc Denoroy
AniRa-Neurochem and BioRaN
Centre de Recherche en Neurosciences de Lyon
Lyon, France

Joseph DeRisi
University of California
San Francisco, California

Ashish Dhir
School of Medicine
University of California Davis Medical Center
Sacramento, California

Jerome DiGiovanni
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Maja Djurisic
Yale University School of Medicine
New Haven, Connecticut

Jean-Cosme Dodart
Eli Lilly and Company
Indianapolis, Indiana

John Donovan
Wyeth-Ayerst Research
Collegeville, Pennsylvania

Robert L. Dorit
Yale University
New Haven, Connecticut

John Drago
Howard Florey Institute
University of Melbourne
Parkville, Victoria, Australia

Robert C. Drugan
University of New Hampshire
Durham, New Hampshire

Alain Dubois
Synthélabo Recherche
Bagneux Cédex, France

F. Edward Dudek
Colorado State University
Fort Collins, Colorado

Henryk Dudek
Ontogeny, Inc.
Cambridge, Massachusetts

Stephanie C. Dulawa
Columbia University
New York, New York

Stephen B. Dunnett
Cardiff University
Cardiff, United Kingdom

Jamie Eberling
University of California Berkeley
Berkeley, California

James Eberwine
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania

Eleanore B. Edson
Stanford University School of Medicine
Stanford, California

Markus U. Ehrengruber
University of Zurich
Zurich, Switzerland

A. Christine Engblom
Royal Danish School of Pharmacy
Copenhagen, Denmark

JoAnne Engebrecht
State University of New York
Stony Brook, New York

Lynn W. Enquist
Princeton University
Princeton, New Jersey

Amy J. Eshleman
Oregon Health Sciences University and Veterans Affairs Medical Center
Portland, Oregon

Michael Graham Espey
National Institute of Diabetes and Digestive & Kidney Diseases
Bethesda, Maryland

Chun X. Falk
RedShirtImaging
Fairfield, Connecticut
and Yale University School of Medicine
New Haven, Connecticut

William A. Falls
The University of Vermont
Burlington, Vermont

Christian C. Felder
Lilly Research Laboratories
Indianapolis, Indiana

Carrie R. Ferrario
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

R. Douglas Fields
National Institute of Child Health and Human Development
National Institutes of Health
Bethesda, Maryland

Sandra E. File
King’s College London
London, United Kingdom

Alan Finkel
Axon Instruments
Foster City, California

David Finkelstein
Howard Florey Institute
University of Melbourne
Parkville, Victoria, Australia

Stephanie D. Fitz
Indiana University Medical Center
Indianapolis, Indiana

Patrick Fitzgerald
University College Cork
Cork, Ireland

Alison S. Fleming
University of Toronto at Mississauga
Mississauga, Canada

Maximillian T. Follettie
Genetics Institute/Wyeth Research
Cambridge, Massachusetts

Cornel Fraefel
Institute of Virology
University of Zurich
Zurich, Switzerland

Kevin B. Freeman
The American University
Washington, D.C.

Kirk A. Frey
University of Michigan
Ann Arbor, Michigan

Christelle Froger
Porsolt and Partners Pharmacology
Boulogne Billancourt, France

Steven Fuller
Nabi
Rockville, Maryland

Beat H. Gähwiler
University of Zurich
Zurich, Switzerland

Bennett G. Galef, Jr.
McMaster University
Hamilton, Ontario, Canada

Sean Gallagher
UVP, Inc.
Upland, California

Raquelli Ganel
Johns Hopkins University
Baltimore, Maryland

Patricia Garcia-Pinto
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Mikhail A. Gavrilin
The Ohio State University
Columbus, Ohio

Christian A. Gerdes
University of Manchester
Manchester, United Kingdom

Charles R. Gerfen
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Claudia Gerwin
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Daniel H. Geschwind
UCLA School of Medicine
Los Angeles, California

Mark A. Geyer
University of California, San Diego
La Jolla, California

Anirvan Ghosh
Johns Hopkins University School of Medicine
Baltimore, Maryland

Michael Gilman
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

Michelle Gilmor
Emory University
Altanta, Georgia

Marianna Goldrick
Ambion, Inc.
Austin, Texas

Erica A. Golemis
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Simon Goodson
University of Sheffield
Sheffield, United Kingdom

Qizhi Gong
School of Medicine
University of California
Davis, California

Shiaoching Gong
Rockefeller University
New York, New York

Frank J. Gottron
Washington University School of Medicine
St. Louis, Missouri

Ginny M. Graczyk
SUNY-HSC at Syracuse
Syracuse, New York

Nicholas J. Grahame
Indiana University/Purdue University at Indianapolis
Indianapolis, Indiana

David K. Grandy
Oregon Health Sciences University
Portland, Oregon

Hernán E. Grecco
Max Planck Institute for Molecular Physiology
Dortmund, Germany

Michael E. Greenberg
Harvard Medical School
Boston, Massachusetts

Guy Griebel
Sanofi-Synthelabo
Paris, France

Steven S. Gross
Cornell University Medical College
New York, New York

Andrew J. Grottick
Arena Pharmaceuticals
San Diego, California

Neil E. Grunberg
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Patricia Guijarro
CAS-MPG Partner Institute for Computational Biology
Shanghai Institutes for Biological Sciences
Chinese Academy of Sciences
Shanghai, China

Tod Gulick
Massachusetts General Hospital
Charlestown, Massachusetts

Fabian Gusovsky
Eisai Research Institute
Andover, Massachusetts

John F. Guzowski
University of Arizona
Tucson, Arizona

Jeno Gyuris
Mitotix, Inc.
Cambridge, Massachusetts

Rebecca A. Haberman
University of North Carolina
Chapel Hill, North Carolina

Jason Halford
University of Liverpool
Liverpool, United Kingdom

Edward D. Hall
Parke-Davis Pharmaceutical Research
Ann Arbor, Michigan

Lori R. Hardy
Philadelphia College of Osteopathic Medicine
Suwanee, Georgia

Julie A. Harris
Allen Institute for Brain Science
Seattle, Washington

Carine Hautbois
Porsolt and Partners Pharmacology
Boulogne-Billancourt, France

Pamela Hawley-Nelson
Life Technologies, Inc.
Rockville, Maryland

Kathleen A. Hayes
The Ohio State University
Columbus, Ohio

Thomas Hazel
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Christian Heidbreder
Swiss Federal Institute of Technology Zurich (ETH)
Schwerzenbach, Switzerland

J. S. Heilig
University of Colorado
Boulder, Colorado

Craig Heilman
Emory University
Altanta, Georgia

Mark L. Heiman
Lilly Research Laboratories
Indianapolis, Indiana

Stephen C. Heinrichs
Neurocrine Biosciences, Inc.
San Diego, California

Jennifer L. Hellier
University of Colorado Health
Sciences Center
Denver, Colorado

Scott C. Henderson
School of Medicine
Virginia Commonwealth University
Richmond, Virginia

Charles J. Heyser
Franklin & Marshall College
Lancaster, Pennsylvania

Tuan Hoang
UCLA School of Medicine
Los Angeles, California

Bartley G. Hoebel
Princeton University
Princeton, New Jersey

James P. Hoeffler
Invitrogen Corporation
Carlsbad, California

Myron A. Hofer
Columbia University and Sackler Institute for Developmental Psychobiology
and New York State Psychiatric Institute
New York, New York

Beth J. Hoffman
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Marie Honore
Abbott Laboratories
Abbott Park, Illinois

Hennie Hoogenboom
Department Pathologie Academisch Ziekenhius Maastricht and TargetQuest
Maastricht, The Netherlands

Malcolm K. Horne
Howard Florey Institute
Univerity of Melbourne
Parkville, Victoria, Australia

Richard L. Huganir
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Igor Huk
University of Vienna
Vienna, Austria

Trevor Humby
Neurobiology Programme
The Babraham Institute
Cambridge, United Kingdom

S. P. Hunt
Medical Research Council Laboratory of Molecular Biology
Cambridge, United Kingdom

John G. R. Hurrell
FluorRx
Carmel, Indiana

Paul A. Hyslop
Eli Lilly & Company
Indianapolis, Indiana

David Ide
National Institutes of Health
Bethesda Maryland

Ernesto Ince
Emory University
Atlanta, Georgia

Jon R. Inglefield
U. S. Environmental Protection Agency
Research Triangle Park, North Carolina

John T. R. Isaac
MRC Centre for Synaptic Plasticity
Bristol, United Kingdom

Mandy Jackson
Johns Hopkins University
Baltimore, Maryland

Meyer B. Jackson
University of Wisconsin Medical School
Madison, Wisconsin

Aaron Janowsky
Oregon Health Sciences University and Veterans Affairs Medical Center
Portland, Oregon

Jonathan A. Javitch
Columbia University
New York, New York

Jian Jiang
Institute of Neuroscience
and State Key Laboratory of Neuroscience
Shanghai Institutes for Biological Sciences
and Graduate School
Chinese Academy of Sciences
Shanghai, China

Kirk W. Johnson
Eli Lilly and Company
Indianapolis, Indiana

Terrance D. Jones
University of Washington
Seattle, Washington

Harry L. June
Indiana University–Purdue University
Indianapolis, Indiana

Bechara Kachar
National Institute on Deafness and Other Communication Disorders
National Institutes of Health
Bethesda, Maryland

Jason A. Kahana
University of California
San Diego, California

Steven D. Kahl
Lilly Research Laboratories
Indianapolis, Indiana

Audrey N. Kalehua
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Peter Kalivas
Washington State University
Pullman, Washington

Robin B. Kanarek
Tufts University
Medford, Massachusetts

Veronica C. Karpiak
Laboratory of Systems Neuroscience
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Stanislav L. Karsten
UCLA School of Medicine
Los Angeles, California

Alan R. Kay
University of Iowa
Iowa City, Iowa

Stanley R. Keim
Indiana University Medical Center
Indianapolis, Indiana

Ann E. Kelley
University of Wisconsin Medical School
Madison, Wisconsin

Donald Kessler
Genomics Corp.
Foster City, California

Paul A. Kingston
University of Manchester
Manchester, United Kingdom

Robert E. Kingston
Massachusetts General Hospital and Harvard Medical School
Boston, Massachusetts

Alexander Klein
Cardiff University
Cardiff, Wales, United Kingdom

Ulrike Klenke
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Malgorzata Kohutnicka
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Bhaskar S. Kolachana
NIMH/Clinical Brain Disorders Branch
Bethesda, Maryland

George F. Koob
The Scripps Research Institute
La Jolla, California

Phillip R. Kramer
NIH, NINDS, CDNS
Bethesda, Maryland

Gabriele Kroner-Lux
University of North Carolina
Chapel Hill, North Carolina

David J. Krupa
University of Iowa
Iowa City, Iowa

Thomas A. Kunkel
National Institute of Environmental Health Sciences
Research Triangle Park, North Carolina

Debomoy K. Lahiri
Institute of Psychiatric Research
and Department of Medical and Molecular Genetics
Indiana University School of Medicine
Indianapolis, Indiana

Andrea S. Laimbacher
University of Zurich
Zurich, Switzerland

Douglas A. Lappi
Advanced Targeting Systems
San Diego, California

Richard T. Layer
Cognetix
Salt Lake City, Utah

Catherine Le Moine
Université Victor Segalen Bordeaux 2
Bordeaux Cedex, France

Eleanor Y. Lee
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Miriam Leenders
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Allan Levey
Emory University
Altanta, Georgia

R. A. Levis
Rush Medical College
Chicago, Illinois

George Liapakis
Columbia University
New York, New York

Filip Lim
Universidad Autonoma de Madrid
Madrid, Spain

Geoffrey S. F. Ling
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Arnold S. Lippa
DOV Pharmaceutical, Inc.
Hackensack, New Jersey

Morgen T. Lippa
DOV Pharmaceutical, Inc.
Hackensack, New Jersey

F. J. Livesey
Trinity College
Dublin, Ireland

Donald C. Lo
Duke University Medical Center
Durham, North Carolina

Daniel J. Lodge
University of Texas Health Science Center at San Antonio
San Antonio, Texas

Joseph S. Lonstein
University of Massachusetts
Amherst, Massachusetts

Pedro R. Lowenstein
University of Manchester
Manchester, United Kingdom

Farah D. Lubin
Department of Neurobiology and Evelyn F. McKnight Brain Institute
University of Alabama at Birmingham
Birmingham, Alabama

Kenneth Lundstrom
F. Hoffmann-LaRoche Research Laboratories
Basel, Switzerland

Larami MacKenzie
UCLA School of Medicine
Los Angeles, California

Karol Mackey
Molecular Research
Cincinnati, Ohio

Daniel V. Madison
Stanford University School of Medicine
Stanford, California

Rafael Maldonado
Laboratori de Neurofarmacologia
University Pompeu Fabra
Barcelona, Spain

Tricia C. Maleniak
University of Manchester
Manchester, United Kingdom

Tadeusz Malinski
Center for Biomedical Research
Oakland University
Rochester, Michigan

Annika B. Malmberg
University of California
San Francisco, California

Dragan Maric
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

John Marshall
Brown University
Providence, Rhode Island

Roberto Marzari
Università di Trieste
Trieste, Italy

Lawrence E. Mathes
The Ohio State University
Columbus, Ohio

Patrick May
Eli Lilly and Company
Indianapolis, Indiana

Margot Mayer-Pröschel
Huntsman Cancer Institute
University of Utah
Salt Lake City, Utah

Richard M. McCarron
Naval Medical Research Center
Silver Spring, Maryland

James S. McCasland
SUNY-HSC at Syracuse
Syracuse, New York

Thomas J. McCown
University of North Carolina
Chapel Hill, North Carolina

Ross A. McDevitt
National Institute on Drug Abuse—Intramural Research Program
National Institutes of Health
Baltimore, Maryland

Lance R. McMahon
Texas A&M University
College Station, Texas

Leslie R. Meek
University of Minnesota at Morris
Morris, Minnesota

Zul Merali
University of Ottawa
Ottawa, Canada

Aaron J. Mercer
University of Michigan
Ann Arbor, Michigan

Eva Mezey
National Institutes of Health
Bethesda, Maryland

Mike Milovanovic
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

David Moore
Baylor College of Medicine
Houston, Texas

Thomas J. Morrow
VA Medical Center
University of Michigan
Ann Arbor, Michigan

Richard Mortensen
Brigham and Women’s Hospital
Boston, Massachusetts

Richard Mortensen
University of Michigan Medical School
Ann Arbor, Michigan

A. Jennifer Morton
University of Cambridge
Cambridge, United Kingdom

Harvey Motulsky
GraphPad Software
San Diego, California

Kevin Mullen
Case Western Reserve University
Cleveland, Ohio

Dominique Muller
University of Geneva
Geneva, Switzerland

Thomas Müller
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Michelle L. Mundorf
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Cheryl Isaac Murphy
Cambridge Biotech Corporation
Worcester, Massachusetts

Philip M. Murphy
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland

Norman Nash
Emory University
Altanta, Georgia

Christopher Nelson
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

Richard Neubig
University of Michigan
Ann Arbor, Michigan

Inga D. Neumann
University of Regensburg
Regensburg, Germany

Kim A. Neve
Oregon Health Sciences University and Veterans Affairs Medical Center
Portland, Oregon

Rachael L. Neve
Massachusetts Institute of Technology
Cambridge, Massachusetts

Douglas Nitz
Neurosciences Institute
La Jolla, California

Ward Odenwald
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Michael J. O’Donovon
National Institute of Neurological Disorders and Stroke, NIH
Bethesda, Maryland

Seung Wook Oh
Allen Institute for Brain Science
Seattle, Washington

Yoshitsugu Oiwa
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Shigeo Okabe
National Institute of Bioscience and Human Technology
Ibaraki, Japan

Hiroto Okayama
Osaka University
Osaka, Japan

Siobhain M. O’Mahony
University College Cork
Cork, Ireland

Michael J. O’Neill
Eli Lilly and Co.
Windlesham, United Kingdom

Abdel-Mouttalib Ouagazzal
United Medical and Dental Schools, Guy’s Hospital
London, United Kingdom

A. K. Pani
NIH/NIDA Intramural Research Program
Bethesda, Maryland

Clare L. Parish
Howard Florey Institute
University of Melbourne
Parkville, Victoria, Australia

R. Ryley Parrish
Department of Neurobiology and Evelyn F. McKnight Brain Institute
University of Alabama at Birmingham
Birmingham, Alabama

Sandrine Parrot
AniRa-Neurochem and BioRaN
Centre de Recherche en Neurosciences de Lyon
Lyon, France

Yvonne Paterson
University of Pennsylvania
Philadelphia, Pennsylvania

Mark Payton
Glaxo-Wellcome
Stevenage, United Kingdom

Kevin J. Petty
Merck & Company
West Point, Pennsylvania

Lee A. Phebus
Eli Lilly and Company
Indianapolis, Indiana

Mary C. Phelan
Thompson Children’s Hospital
Chattanooga, Tennessee

R. Christopher Pierce
Washington State University
Pullman, Washington

Simon Pitchford
Molecular Devices Corporation
Sunnyvale, California

Helen Piwnica-Worms
Washington University School of Medicine
St. Louis, Missouri

Donna M. Platt
New England Primate Research Center
Harvard Medical School
Southborough, Massachusetts

Dietmar Plenz
Laboratory of Systems Neuroscience
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland

Michael Podell
The Ohio State University
Columbus, Ohio

Nicholas Poolos
University of Washington
Seattle Washington

Roger D. Porsolt
Porsolt and Partners Pharmacology
Boulogne-Billancourt, France

Huntington Potter
Harvard Medical School
Boston, Massachusetts

Michael K. Racke
University of Texas
Southwestern Medical Center at Dallas
Dallas, Texas

Richard A. Radcliffe
University of Colorado
Denver, Colorado

Kathryn R. Radford
Australian Membrane and Biotechnology Research
Sydney, Australia

James L. Rae
Mayo Foundation
Rochester, Minnesota

Balmiki Ray
Institute of Psychiatric Research
Indiana University School of Medicine
Indianapolis, Indiana

Louise Rem
Department Pathologie Academisch Ziekenhius Maastricht and TargetQuest
Maastricht, The Netherlands

Diego Restrepo
University of Colorado Health Sciences Center
Denver, Colorado

Ian J. Reynolds
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Randall Ribaudo
National Institute of Allergy and Infectious Disease
Bethesda, Maryland

Anthony L. Riley
The American University
Washington D.C.

Katherine W. Roche
National Institute on Deafness and Other Communication Disorders
National Institutes of Health
Bethesda, Maryland

John K. Rose
Yale University School of Medicine
New Haven, Connecticut

Glenn D. Rosen
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Mark A. Rossi
Department of Neurobiology and Evelyn F. McKnight Brain Institute
University of Alabama at Birmingham
Birmingham, Alabama

Jeffrey D. Rothstein
Johns Hopkins University
Baltimore, Maryland

Sylvain Roux
Porsolt and Partners Pharmacology
Boulogne-Billancourt, France

Nicoletta Sacchi
Johns Hopkins University
Baltimore, Maryland

R. N. S. Sachdev
The University of Texas at San Antonio
San Antonio, Texas

Tammy J. Sajdyk
Indiana University Medical Center
Indianapolis, Indiana

Richard Jude Samulski
University of North Carolina
Chapel Hill, North Carolina

Rosario Sanchez-Pernaute
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Martin Sarter
The Ohio State University
Columbus, Ohio

Carmen Sato-Bigbee
Medical College of Virginia
Virginia Commonwealth University
Richmond, Virginia

Richard C. Saunders
NIMH/Clinical Brain Disorders Branch
Bethesda, Maryland

Daniele Sblattero
International School for Advanced Studies (SISSA)
Trieste, Italy

Bernard Scatton
Synthélabo Recherche
Bagneux Cédex, France

John A. Schetz
University of North Texas Health Science Center
Fort Worth, Texas

Michael I. Schimerlik
Oregon State University
Corvallis, Oregon

Rochelle D. Schwartz-Bloom
Duke University Medical Center
Durham, North Carolina

Anthony Sclafani
Brooklyn College of the City University of New York
Brooklyn, New York

Rosalind A. Segal
Beth Israel Deaconess Medical Center and Harvard Medical School
Boston, Massachusetts

Yoshitatsu Sei
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Christine E. Seidman
Harvard Medical School
Boston, Massachusetts

Ze’ev Seltzer
University of Toronto
Toronto, Ontario, Canada

Ilya Serebriiskii
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Harry N. Shair
Columbia University and Sackler Institute for Developmental Psychobiology and New York State Psychiatric Institute
New York, New York

Eswar P. N. Shankar
University of North Texas Health Science Center
Fort Worth, Texas

Jun Shao
Vanderbilt University
Nashville, Tennessee

Michael C. Shaughness
Naval Medical Research Center
Silver Spring, Maryland

Anantha Shekhar
Indiana University Medical Center
Indianapolis, Indiana

Keith L. Shelton
Virginia Commonwealth University
Richmond, Virginia

Zu-Hang Sheng
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Toni S. Shippenberg
NIH/NIDA Intramural Research Program
Baltimore, Maryland

Pam A. Silver
Dana-Farber Cancer Institute
Boston, Massachusetts

Jay R. Simon
Institute of Psychiatric Research
Indiana University School of Medicine
Indianapolis, Indiana

Merrill M. Simpson
Columbia University
New York, New York

Cheryl L. Sisk
Michigan State University
East Lansing, Michigan

David A. Slattery
University of Regensburg
Regensburg, Germany

Burton Slotnick
University of South Florida
Tampa, Florida

Carolyn L. Smith
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Gerard P. Smith
Cornell University Medical College and New York Hospital–Cornell Medical Center
White Plains, New York

Thomas D. Southgate
University of Manchester
Manchester, United Kingdom

Roger D. Spealman
New England Primate Research Center
Harvard Medical School
Southborough, Massachusetts

Kenneth R. Spring
National Heart, Lung and Blood Institute
National Institutes of Health
Bethesda, Maryland

Timothy A. Springer
Center for Blood Research
Harvard Medical School
Boston, Massachusetts

Dejan Zecevic Srdjan
Yale University School of Medicine
New Haven, Connecticut

Daniel Stone
University of Manchester
Manchester, United Kingdom

Daniel R. Storm
University of Washington
Seattle, Washington

Catherine D. Strader
Schering-Plough Research Institute
Kenilworth, New Jersey

William M. Strauss
Harvard Medical School and Beth Israel Deaconess Medical Center
Boston, Massachusetts

Kevin Struhl
Harvard Medical School
Boston, Massachusetts

Greg Stuart
John Curtin School of Medical Research
Australian National University
Canberra, Australia

Lorenz Studer
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Tao Sun
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

Geoffrey T. Swanson
University of Texas Medical Branch
Galveston, Texas

Neal R. Swerdlow
University of California, San Diego
La Jolla, California

Ronald Szymusiak
University of California
Los Angeles, California

Vivian Tabar
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

James P. Tam
Vanderbilt University
Nashville, Tennessee

Cha-Min Tang
University of Maryland School of Medicine
Baltimore, Maryland

Carol Taylor-Burds
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, Maryland

James M. Tepper
Rutgers University Center for Molecular and Behavioral Neuroscience
Newark, New Jersey

Shelley R. Thielen
Indiana University Medical Center
Indianapolis, Indiana

Clare E. Thomas
University of Manchester
Manchester, United Kingdom

Morgane Thomsen
McLean Hospital-Harvard Medical School
Belmont, Massachusetts
and University of Copenhagen
Copenhagen, Denmark

Alexis C. Thompson
NIH/NIDA Intramural Research Program
Baltimore, Maryland

Scott M. Thompson
University of Maryland School of Medicine
Baltimore, Maryland

Wallace B. Thoreson
University of Nebraska Medical Center
Omaha, Nebraska

Sarah Tomaszewski Farias
University of Essex
Colchester, United Kingdom

Iulia Toth
University of Regensburg
Regensburg, Germany

Jordan Tozer
School of Medicine
Virginia Commonwealth University
Richmond, Virginia

Monica Tramullas
University College Cork
Cork, Ireland

Didier Trono
University of Geneva
Geneva, Switzerland

C. Diane True
NEN Life Science Products
North Billerica, Massachusetts

Laurence Trussell
Oregon Health Sciences University
Portland, Oregon

Matthias Tschöp
Lilly Research Laboratories
Indianapolis, Indiana

Olga Valverde
Laboratori de Neurofarmacologia
University Pompeu Fabra
Barcelona, Spain

K.E. Vanover
ACADIA Pharmaceuticals
San Diego, California

Carlos Vicario-Abejón
Centro de Investigaciones Biológicas
Censejo Superior de Investigaciones Cientificas
Madrid, Spain

Christopher S. von Bartheld
University of Nevada School of Medicine
Reno, Nevada

Daniel Voytas
Iowa State University
Ames, Iowa

Matt Wachowiak
Yale University School of Medicine
New Haven, Connecticut

Jeanne M. Wehner
University of Colorado
Boulder, Colorado

Daniel R. Weinberger
NIMH/Clinical Brain Disorders Branch
Bethesda, Maryland

Ina Weiner
Tel-Aviv University
Tel-Aviv, Israel

David E. Weinstein
GliMed Inc.
New York, New York

Ben Avi Weissman
Israel Institute for Biological Research
Ness Ziona, Israel

Paul J. Wellman
Texas A&M University
College Station, Texas

Gary L. Wenk
University of Arizona
Tucson, Arizona

Kevin Whelan
Arena Pharmaceuticals
San Diego, California

Maryann Z. Whitley
Genetics Institute/Wyeth Research
Cambridge, Massachusetts

Michael Whitt
University of Tennessee
Memphis, Tennessee

Scott R. Whittemore
University of Miami School of Medicine
Miami, Florida

R. Mark Wightman
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Ronald G. Wiley
Veterans Affairs Medical Center
Nashville, Tennessee

Lawrence Wilkinson
Neurobiology Programme
The Babraham Institute
Cambridge, United Kingdom

Robert W. Williams
University of Tennessee Health Science Center
Memphis, Tennessee

Charles J. Wilson
The University of Texas at San Antonio
San Antonio, Texas

James T. Winslow
Center for Behavioral Neuroscience
Yerkes Regional Primate Research Center and Emory Medical School
Atlanta, Georgia

Scott E. Winston
Nabi
Rockville, Maryland

Marina E. Wolf
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois

Paul F. Worley
Johns Hopkins University School of Medicine
Baltimore, Maryland

Floris G. Wouterlood
Vrije Universiteit Medical Center
Amsterdam, The Netherlands

Craige C. Wrenn
Laboratory of Behavioral Neuroscience
National Institute of Mental Health
Bethesda, Maryland

Rina Wu
Albert Einstein College of Medicine
Bronx, New York

X. William Yang
Department of Psychiatry and Biobehavioral Sciences
Center for Neurobehavioral Genetics
Neuropsychiatric Institute
David Geffen School of Medicine at UCLA
Los Angeles, California

Angela M. Yarnell
Uniformed Services University of the Health Sciences
Bethesda, Maryland

Henry H. Yin
Center for Cognitive Neuroscience
Duke University
Durham, North Carolina

Howard S. Ying
Washington University School of Medicine
St. Louis, Missouri

W. Scott Young, III
National Institutes of Health
Bethesda, Maryland

Xiao-bing Yuan
Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education)
Shanghai Jiao Tong University
Shanghai, China

Agustin Zapata
National Institute on Drug Abuse Intramural Research Program
National Institutes of Health
Baltimore, Maryland

Hongkui Zeng
Allen Institute for Brain Science
Seattle, Washington

Michal R. Zochowski
Warsaw School of Advanced Social Psychology
Warsaw, Poland
and Yale University School of Medicine
New Haven, Connecticut

Romain Zufferey
University of Geneva
Geneva, Switzerland